Vizma Life Sciences, Inc

Pine Research Instrumentation, based in Durham, NC, specializes in providing a wide range of high-quality electrochemical instruments and accessories for research and educational purposes. Their product line includes electrode rotators, potentiostats, electrochemical cells, custom designs, and accessories such as electrode holders and probes. With a focus on innovation and quality, Pine Research Instrumentation offers comprehensive solutions for various applications, including corrosion studies, neuroelectrochemistry, spectroelectrochemistry, and photoelectrochemistry. Their dedication to advancing the field of electrochemistry is evident through their range of products and educational resources, making them a trusted partner for researchers and educators worldwide.Generated from the website

Since 1958, Troxler Electronic Laboratories has been the worldwide leader in precision quality control and measurement equipment for the highway and construction industry. The company provides full-service, training and maintenance support for all of its products through its international sales and support offices in the U.S., Canada, Germany and through worldwide distributors. All Troxler products are tested to guarantee quality, dependability and performance and are backed by the industry s leading warranties.

AlphaVax Human Vaccines Inc., based in Durham, NC, is a privately-held clinical-stage biopharmaceutical company specializing in the development of innovative vaccines utilizing its proprietary RNA particle alphavaccine vector platform technology. The company focuses on anti-infective and anti-cancer vaccines, aiming to redefine their roles in medicine through a strategic approach that includes commercial partnerships for specific disease applications. With a portfolio of seven vaccine candidates targeting infectious diseases and cancer immunotherapy, AlphaVax has conducted multiple Phase 1 clinical trials. Its research highlights include encouraging results in cancer treatments, such as enhanced survival in patients with Stage IV colon cancer, showcasing the potential of its alphavaccine technology to engage the immune system effectively. Generated from the website